Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 55,093 | -10,912 | -2,354 | -76,698 | -68,362 |
| Depreciation Amortization | 1,714 | 1,626 | 749 | 1,015 | 765 |
| Accounts receivable | -5,196 | -4,072 | -6,278 | 5,323 | -6,314 |
| Accounts payable and accrued liabilities | 1,215 | 2,167 | 3,813 | 4,474 | 4,044 |
| Other Working Capital | 443 | 1,062 | -2,789 | 6,018 | 1,455 |
| Other Operating Activity | -62,067 | 3,695 | 1,919 | -10,542 | 4,533 |
| Operating Cash Flow | $-8,798 | $-6,434 | $-4,940 | $-70,410 | $-63,879 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -4 | -3 | -341 | -306 |
| Investing Cash Flow | $-4 | $-4 | $-3 | $-341 | $-306 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,262 | 2,138 | 1,640 | 11,500 | 10,000 |
| Debt Repayment | -1,000 | N/A | N/A | -5,892 | -5,892 |
| Common Stock Issued | 174 | 160 | 61 | 57,551 | 57,551 |
| Common Stock Repurchased | N/A | N/A | N/A | -18 | -18 |
| Other Financing Activity | 0 | 0 | 0 | -1,202 | -1,202 |
| Financing Cash Flow | $4,436 | $2,298 | $1,701 | $61,939 | $60,439 |
| Beginning Cash Position | 4,776 | 4,776 | 4,776 | 13,588 | 13,588 |
| End Cash Position | 410 | 636 | 1,534 | 4,776 | 9,842 |
| Net Cash Flow | $-4,366 | $-4,140 | $-3,242 | $-8,812 | $-3,746 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,798 | -6,434 | -4,940 | -70,410 | -63,879 |
| Capital Expenditure | -4 | -4 | -3 | -341 | -306 |
| Free Cash Flow | -8,802 | -6,438 | -4,943 | -70,751 | -64,185 |